𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

✍ Scribed by Roslyn Yomtovian; Waldemar Niklinski; Bernard Silver; Ravindra Sarode; Han-Mou Tsai

Book ID
108672525
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
403 KB
Volume
124
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Thrombotic thrombocytopenic purpura and
Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review
✍ Ali Shamseddine; Aref Chehal; Ihab Usta; Ziad Salem; Nagi El-Saghir; Ali Taher πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract Thrombotic thrombocytopenic purpura (TTP) is a severe life‐threatening hematological disorder affecting the microcirculation of multiple organ systems. Infection, pregnancy, cancer, drugs, and surgery are frequently associated with the initial episodes and relapses. Women who are either

Rituximab for the treatment of refractor
Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases
✍ Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 162 KB πŸ‘ 2 views

Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp